TABLE 2.
Results of supplementary testing using the BD Max GC real-time PCR assay on samples positive for Neisseria gonorrhoeae in the BD ProbeTec GC Qx amplified DNA assay run on the BD Viper system
No. of samples BD Viper positive | No. of samples positive/negative by BD Max GC real-time PCR confirmatory testing |
|||||||
---|---|---|---|---|---|---|---|---|
Positive | Negative (% of BD Viper positive)a |
|||||||
Male |
Female |
|||||||
Pharynx | Urine | Rectum | Pharynx | Vaginal | Urine | Cervix | ||
322 | 252 | 27 (33) | 19 (14) | 3 (15) | 8 (57) | 8 (24) | 4 (50) | 1 (33) |
All 70 negative samples were negative also in the Aptima Combo 2 NAAT (Hologic); however, one of the vaginal samples was repeatedly positive in the gonococcal dual-target PCR (21).